Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday newspaper round-up: White Hydrogen, Bank of England, AI

(Sharecast News) - America's Geological survey estimates that if even a small fraction of naturally occurring - and clean or so-called 'white' - hydrogen beneath the earth's surface were recovered, that would last for hundreds of years. Among the backers of the hydrogen industry is Bill Gates, who ploughed $90m into Koloma, a company hunting for natural hydrogen along the US's Midcontinental Rift System. White hydrogen has also been discovered in Europe, in France's Lorraine region. Nonetheless, the true potential of the stuff will hinge on the findings from those early projects, says Philip Ball, research fellow at Keele University. - Guardian The UK's 'pancake like' economy may fall into a recession induced by the Bank of England's policies, according to its former chief economist, Andy Haldane. "It's stuck. The economy's stuck. In growth terms, it's been treading water for at least a year," he said. "And looking ahead, if you believe the forecasts, it seems set to remain largely stuck for the months and quarters ahead." The country's economy remains the only one out of the G-7 that has yet to recover its pre-pandemic size. In the case of wages, those of younger workers had dropped since 2008 by the most since the nineteenth century. Yet he remained optimistic, pointing out the scope for boosting the size of the overall workforce. - Sunday Telegraph

Artificial Intelligence may dramatically cut the time needed to develop new medicines, GlaxoSmithKline said. The drugmaker had also begun using AI to tailor drugs to patients, thus increasing their effectiveness. It AI hubs are also helping speed up clinical trials. Some stages of trials, such as analysing data, are being sped up by a factor of five. AI is also helping scientists assess hundreds of the potential causes of a disease in the same amount of time previously requierd to study just one cause. - Financial Mail on Sunday

Entain is looking into whether it can claw back tens of millions paid out in bonuses to former bosses as it faces a potential £600m fine from a criminal investigation into its Turkish unit. That would be one of the biggest criminal fines ever levied by the Crown Prosecution Service in the UK's corporate history. HMRC's investigation involved GVC's - Entain's previous name - use of third party suppliers to use third-party suppliers to process payments that in turn allowed GVC to offer online gambling services in Turkey. - The Sunday Times

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Thames Water, mortgage costs, UK car production
(Sharecast News) - Thames Water has breached its licence to supply water to nearly 16 million people after some of its debt was downgraded to junk status. The regulator Ofwat could now fine Thames, the country's largest water monopoly, up to 10% of its annual turnover, equating to hundreds of millions of pounds. However, since the company is already teetering close to temporary renationalisation, Ofwat is likely to hold off on any immediate large fines. - Guardian
Wednesday newspaper round-up: Reckitt, Tesla, Virgin Atlantic...
(Sharecast News) - Reckitt is under pressure from top shareholders to revisit a sale of its nutrition business, following litigation and a series of other setbacks at the division that have sent the company's share price to decade lows. The FTSE 100 consumer giant acquired the Mead Johnson infant formula business in 2017 for $17bn - its largest-ever acquisition - and it has been plagued by mishaps ever since. Meanwhile, the wider group, which makes Lysol detergent and Durex condoms, has underwhelmed investors as it struggles to build back sales volumes following a period of high inflation and suppressed consumer demand. - Financial Times
Tuesday newspaper round-up: Kamala Harris, Crowdstrike, Vivendi...
(Sharecast News) - Kamala Harris has secured enough delegates from her party to clinch the Democratic presidential nomination, as she pledged to offer Americans a "brighter future" compared to the "chaos, fear and hate" proposed by Donald Trump. The US vice-president was speaking in Wilmington, Delaware, on Monday, the first full day since President Joe Biden dropped his re-election bid and endorsed her for the Democratic presidential nomination, shaking up the 2024 race for the White House. - Financial Times
Monday newspaper round-up: Biden, gambling levy, UK economy...
(Sharecast News) - Kamala Harris, the vice-president, has emerged as the frontrunner to replace President Biden as the Democratic nominee for the election against Donald Trump in November. Biden, 81, announced yesterday afternoon that he would drop out of the race. In the hours that followed, Harris, 59, was endorsed by leading Democrats, prospective rivals and the chairs of all 50 state parties. - The Times

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.